News
ANGO
13.10
-0.46%
-0.06
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
NASDAQ · 3d ago
Press Release: AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
Dow Jones · 4d ago
AngioDynamics Inc. to Report Fiscal Q2 Results and Hold Conference Call
Reuters · 4d ago
Weekly Report: what happened at ANGO last week (1215-1219)?
Weekly Report · 5d ago
Buy Rating for AngioDynamics Driven by New Clinical Trial and Product Synergy
TipRanks · 12/15 12:05
Weekly Report: what happened at ANGO last week (1208-1212)?
Weekly Report · 12/15 09:08
Weekly Report: what happened at ANGO last week (1201-1205)?
Weekly Report · 12/08 09:08
The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet
Simply Wall St · 12/05 10:12
Weekly Report: what happened at ANGO last week (1124-1128)?
Weekly Report · 12/01 09:07
Canaccord Genuity Remains a Buy on AngioDynamics (ANGO)
TipRanks · 11/25 11:56
Weekly Report: what happened at ANGO last week (1117-1121)?
Weekly Report · 11/24 09:08
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
NASDAQ · 11/21 15:50
Weekly Report: what happened at ANGO last week (1110-1114)?
Weekly Report · 11/17 09:08
AngioDynamics Announces Board Election at Annual Meeting
TipRanks · 11/12 12:37
AngioDynamics Inc. Held Annual Shareholder Meeting
Reuters · 11/12 12:02
Weekly Report: what happened at ANGO last week (1103-1107)?
Weekly Report · 11/10 09:07
Weekly Report: what happened at ANGO last week (1027-1031)?
Weekly Report · 11/03 09:07
Angiodynamics’ Innovative Study on Colorectal Liver Metastases Treatment: A Potential Game-Changer
TipRanks · 10/27 22:24
Angiodynamics’ New Study on Liver Cancer Treatment: A Potential Game Changer
TipRanks · 10/27 22:19
AngioDynamics’ AlphaVac System: A New Hope for Pulmonary Embolism Treatment?
TipRanks · 10/27 21:22
More
Webull provides a variety of real-time ANGO stock news. You can receive the latest news about Angiodynamics through multiple platforms. This information may help you make smarter investment decisions.
About ANGO
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.